| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.60M | 44.40M | -47.80M | 45.50M | 350.90M | 12.51M |
| Gross Profit | 57.40M | 31.70M | -47.80M | 44.70M | 349.50M | 11.60M |
| EBITDA | 79.30M | 500.00K | -49.90M | -283.00M | 325.80M | 273.25M |
| Net Income | 111.20M | -800.00K | -40.60M | -243.40M | 300.70M | 267.40M |
Balance Sheet | ||||||
| Total Assets | 1.43B | 1.38B | 1.36B | 1.32B | 1.50B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 77.00M | 89.00M | 57.00M | 22.90M | 75.80M | 158.40M |
| Total Debt | 121.20M | 121.30M | 89.40M | 89.30M | 30.40M | 600.00K |
| Total Liabilities | 141.20M | 147.20M | 110.50M | 121.70M | 71.10M | 10.63M |
| Stockholders Equity | 1.29B | 1.24B | 1.25B | 1.19B | 1.43B | 1.03B |
Cash Flow | ||||||
| Free Cash Flow | -200.00K | 33.50M | -22.00M | -24.80M | -28.20M | -7.17M |
| Operating Cash Flow | 100.00K | 33.90M | -22.00M | -24.80M | -28.10M | -7.02M |
| Investing Cash Flow | 65.10M | -400.00K | 12.00M | -90.10M | -185.00M | 77.57M |
| Financing Cash Flow | -27.20M | -1.70M | 44.30M | 51.10M | 128.10M | 60.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £26.36B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
73 Outperform | £449.87M | 7.48 | 44.99% | 5.73% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | £827.51M | -13.06 | 5.07% | 2.47% | 66.53% | 100.92% | |
63 Neutral | £923.70M | 2.30 | 8.81% | ― | 11.00% | ― | |
61 Neutral | £538.89M | 8.09 | 7.16% | ― | -35.12% | ― | |
54 Neutral | £2.27B | 56.55 | 4.25% | 2.85% | 47.14% | -37.72% |